{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T04:42:22Z","timestamp":1779338542508,"version":"3.51.4"},"reference-count":33,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100020961","name":"Copenhagen School of Energy Infrastructure","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020961","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["CGV-186957"],"award-info":[{"award-number":["CGV-186957"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000161","name":"Networks of Centres of Excellence of Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000161","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transfusion Medicine Reviews"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.tmrv.2025.150897","type":"journal-article","created":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T17:57:59Z","timestamp":1744135079000},"page":"150897","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Identifying Modifiers of CAR T-Cell Therapeutic Efficacy and Safety: A Systematic Review and Individual Patient Data Meta-Analysis"],"prefix":"10.1016","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0322-382X","authenticated-orcid":false,"given":"Manoj M","family":"Lalu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samuel","family":"Igweokpala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natasha","family":"Kekre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew S","family":"Jeffers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joshua","family":"Montroy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maryam","family":"Ghiasi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kevin","family":"Hay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Scott","family":"McComb","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Risini","family":"Weeratna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harold","family":"Atkins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian","family":"Hutton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayel","family":"Yahya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashish","family":"Masurekar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philippe","family":"Giguere","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elham","family":"Sabri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamad","family":"Sobh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3389-2485","authenticated-orcid":false,"given":"Dean A","family":"Fergusson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.tmrv.2025.150897_bib0001","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/j.bbmt.2013.04.014","article-title":"Outcomes of adults with acute lymphoblastic leukemia relapsing after allogeneic hematopoietic stem cell transplantation","volume":"19","author":"Poon","year":"2013","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.tmrv.2025.150897_bib0002","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1038\/bmt.2016.213","article-title":"Outcomes of diffuse large B-cell lymphoma patients relapsing after autologous stem cell transplantation: an analysis of patients included in the CORAL study","volume":"52","author":"Van Den Neste","year":"2017","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.tmrv.2025.150897_bib0003","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1056\/NEJMoa1407222","article-title":"Chimeric antigen receptor T cells for sustained remissions in leukemia","volume":"371","author":"Maude","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.tmrv.2025.150897_bib0004","doi-asserted-by":"crossref","first-page":"2531","DOI":"10.1056\/NEJMoa1707447","article-title":"Axicabtagene ciloleucel CAR T-cell therapy in refractory large B-cell lymphoma","volume":"377","author":"Neelapu","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.tmrv.2025.150897_bib0005","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1056\/NEJMoa1804980","article-title":"Tisagenlecleucel in adult relapsed or refractory diffuse large B-cell lymphoma","volume":"380","author":"Schuster","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.tmrv.2025.150897_bib0006","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1056\/NEJMoa1914347","article-title":"KTE-X19 CAR T-cell therapy in relapsed or refractory mantle-cell lymphoma","volume":"382","author":"Wang","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.tmrv.2025.150897_bib0007","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1056\/NEJMoa2116133","article-title":"Axicabtagene Ciloleucel as second-line therapy for large B-cell lymphoma","volume":"386","author":"Locke","year":"2022","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.tmrv.2025.150897_bib0008","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1056\/NEJMoa2213614","article-title":"Ide-cel or standard regimens in relapsed and refractory multiple myeloma","volume":"388","author":"Paula","year":"2023","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.tmrv.2025.150897_bib0009","unstructured":"Research C for BE and. Approved Cellular and Gene Therapy Products. FDA 2023."},{"key":"10.1016\/j.tmrv.2025.150897_bib0010","article-title":"Juno pulls the plug on a once-promising cancer treatment","author":"Garde","year":"2017","journal-title":"STAT"},{"key":"10.1016\/j.tmrv.2025.150897_bib0011","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1158\/2326-6066.CIR-13-0006","article-title":"T cells expressing chimeric antigen receptors can cause anaphylaxis in humans","volume":"1","author":"Maus","year":"2013","journal-title":"Cancer Immunol Res"},{"key":"10.1016\/j.tmrv.2025.150897_bib0012","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.tmrv.2019.01.005","article-title":"Risks and benefits of chimeric antigen receptor T-cell (CAR-T) therapy in cancer: a systematic review and meta-analysis","volume":"33","author":"Grigor","year":"2019","journal-title":"Transfus Med Rev"},{"key":"10.1016\/j.tmrv.2025.150897_bib0013","doi-asserted-by":"crossref","first-page":"c221","DOI":"10.1136\/bmj.c221","article-title":"Meta-analysis of individual participant data: rationale, conduct, and reporting","volume":"340","author":"Riley","year":"2010","journal-title":"BMJ"},{"key":"10.1016\/j.tmrv.2025.150897_bib0014","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1111\/j.1749-6632.1993.tb26345.x","article-title":"The Cochrane collaboration: preparing, maintaining, and disseminating systematic reviews of the effects of health care","volume":"703","author":"Chalmers","year":"1993","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.tmrv.2025.150897_bib0015","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1016\/j.jclinepi.2015.05.024","article-title":"How individual participant data meta-analyses have influenced trial design, conduct, and analysis","volume":"68","author":"Tierney","year":"2015","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.tmrv.2025.150897_bib0016","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1186\/s12874-019-0817-6","article-title":"Statistical approaches to identify subgroups in meta-analysis of individual participant data: a simulation study","volume":"19","author":"Belias","year":"2019","journal-title":"BMC Med Res Methodol"},{"key":"10.1016\/j.tmrv.2025.150897_bib0017","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1177\/0163278702025001006","article-title":"To IPD or not to IPD? Advantages and disadvantages of systematic reviews using individual patient data","volume":"25","author":"Stewart","year":"2002","journal-title":"Eval Health Prof"},{"key":"10.1016\/j.tmrv.2025.150897_bib0018","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/S0140-6736(06)69121-6","article-title":"Hyperfractionated or accelerated radiotherapy in head and neck cancer: a meta-analysis","volume":"368","author":"Bourhis","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.tmrv.2025.150897_bib0019","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.lungcan.2013.02.005","article-title":"PORT Meta-analysis Trialist Group. A closer look at the effects of postoperative radiotherapy by stage and nodal status: updated results of an individual participant data meta-analysis in non-small-cell lung cancer","volume":"80","author":"Burdett","year":"2013","journal-title":"Lung Cancer"},{"key":"10.1016\/j.tmrv.2025.150897_bib0020","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1001\/jama.2015.3656","article-title":"Preferred reporting items for systematic review and meta-analyses of individual participant data: the PRISMA-IPD Statement","volume":"313","author":"Stewart","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/j.tmrv.2025.150897_bib0021","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.jclinepi.2016.01.021","article-title":"PRESS Peer Review of Electronic search strategies: 2015 guideline statement","volume":"75","author":"McGowan","year":"2016","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.tmrv.2025.150897_bib0022","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1186\/s12874-020-00964-6","article-title":"Obtaining and managing data sets for individual participant data meta-analysis: scoping review and practical guide","volume":"20","author":"Ventresca","year":"2020","journal-title":"BMC Med Res Methodol"},{"key":"10.1016\/j.tmrv.2025.150897_bib0023","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.jclinepi.2015.07.010","article-title":"A principal component analysis is conducted for a case series quality appraisal checklist","volume":"69","author":"Guo","year":"2016","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.tmrv.2025.150897_bib0024","doi-asserted-by":"crossref","unstructured":"Shuster JJ. Review: Cochrane handbook for systematic reviews for interventions, version 5.1.0, published 3\/2011. JPT Higgins and S Green, Editors. Research Synthesis Methods 2011;2:126-30. https:\/\/doi.org\/10.1002\/jrsm.38.","DOI":"10.1002\/jrsm.38"},{"key":"10.1016\/j.tmrv.2025.150897_bib0025","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2019-034714","article-title":"Safety and efficacy of autologous tumour cell vaccines as a cancer therapeutic to treat solid tumours and haematological malignancies: a meta-analysis protocol for two systematic reviews","volume":"10","author":"Khan","year":"2020","journal-title":"BMJ Open"},{"key":"10.1016\/j.tmrv.2025.150897_bib0026","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0060650","article-title":"Individual participant data meta-analysis for a binary outcome: one-stage or two-stage?","volume":"8","author":"Debray","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.tmrv.2025.150897_bib0027","doi-asserted-by":"crossref","first-page":"e816","DOI":"10.1016\/S2352-3026(20)30277-5","article-title":"Anti-CD19 chimeric antigen receptor T-cell therapy in acute lymphocytic leukaemia: a systematic review and meta-analysis","volume":"7","author":"Anagnostou","year":"2020","journal-title":"Lancet Haematol"},{"key":"10.1016\/j.tmrv.2025.150897_bib0028","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1178403","article-title":"A systematic review and meta-analysis of CD22 CAR T-cells alone or in combination with CD19 CAR T-cells","volume":"14","author":"Fergusson","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.tmrv.2025.150897_bib0029","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1111\/ejh.13851","article-title":"CAR-T cell therapy for patients with hematological malignancies. A systematic review","volume":"109","author":"Pasqui","year":"2022","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.tmrv.2025.150897_bib0030","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1038\/s41571-021-00530-z","article-title":"A comparison of chimeric antigen receptors containing CD28 versus 4-1BB costimulatory domains","volume":"18","author":"Cappell","year":"2021","journal-title":"Nature Rev Clin Oncol"},{"key":"10.1016\/j.tmrv.2025.150897_bib0031","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1186\/2046-4053-3-107","article-title":"Impact of contacting study authors to obtain additional data for systematic reviews: diagnostic accuracy studies for hepatic fibrosis","volume":"3","author":"Selph","year":"2014","journal-title":"Syst Rev"},{"key":"10.1016\/j.tmrv.2025.150897_bib0032","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s12874-019-0685-0","article-title":"Evaluating the effectiveness, efficiency, cost and value of contacting study authors in a systematic review: a case study and worked example","volume":"19","author":"Cooper","year":"2019","journal-title":"BMC Med Res Methodol"},{"key":"10.1016\/j.tmrv.2025.150897_bib0033","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.jclinepi.2019.07.001","article-title":"Contacting of authors modified crucial outcomes of systematic reviews but was poorly reported, not systematic, and produced conflicting results","volume":"115","author":"Meursinge","year":"2019","journal-title":"J Clin Epidemiol"}],"container-title":["Transfusion Medicine Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0887796325000203?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0887796325000203?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T03:22:41Z","timestamp":1762312961000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0887796325000203"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":33,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["S0887796325000203"],"URL":"https:\/\/doi.org\/10.1016\/j.tmrv.2025.150897","relation":{},"ISSN":["0887-7963"],"issn-type":[{"value":"0887-7963","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Identifying Modifiers of CAR T-Cell Therapeutic Efficacy and Safety: A Systematic Review and Individual Patient Data Meta-Analysis","name":"articletitle","label":"Article Title"},{"value":"Transfusion Medicine Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tmrv.2025.150897","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"150897"}}